TIMM17A and breast cancer: By measuring the expression levels of TIMM17A in breast cancer tissues and adjacent normal tissues, we found TIMM17A levels were up-regulated in 87.5% (35 of 40 paired) of breast cancer tissues compared with adjacent normal tissues (Figure 4I) and negatively correlated with miR-133b levels (Figure 4J).